Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-10-2022 | Joint Pain | Clinical study

AEs in children after Pfizer-BioNTech COVID-19 vaccine

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Adverse events (AEs) after the Pfizer-BioNTech COVID-19 vaccine [BNT162b2; tozinameran] are more frequent in children with allergic diseases than in children without allergies, according to findings of a study published in the European Journal of Pediatrics.
Literature
go back to reference Yoshida M, et al. Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5-11 years and comparison with individuals aged 12-15 years: an observational and historical cohort study European Journal of Pediatrics : 21 Oct 2022. Available from: URL: https://doi.org/10.1007/s00431-022-04643-0 Yoshida M, et al. Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5-11 years and comparison with individuals aged 12-15 years: an observational and historical cohort study European Journal of Pediatrics : 21 Oct 2022. Available from: URL: https://​doi.​org/​10.​1007/​s00431-022-04643-0
Metadata
Title
AEs in children after Pfizer-BioNTech COVID-19 vaccine
Publication date
01-10-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26270-6

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Dexamethasone

Case report

Thioctic-acid

Case report

Antineoplastics